PortfoliosLab logoPortfoliosLab logo
Cibus Global LLC (CBUS)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Jun 1, 2023

Highlights

Market Cap
$906.00M
Enterprise Value
$932.28M
EPS (TTM)
-$0.69
Total Revenue (TTM)
$3.64M
Gross Profit (TTM)
$1.19M
EBITDA (TTM)
-$92.28M
Year Range
$1.09 - $4.19
Target Price
$11.50
ROA (TTM)
-41.66%
ROE (TTM)
-582.18%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Cibus Global LLC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cibus Global LLC, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Cibus Global LLC (CBUS) has returned 13.79% so far this year and 5.88% over the past 12 months.


Cibus Global LLC

1D
8.79%
1M
-46.34%
YTD
13.79%
6M
53.49%
1Y
5.88%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jun 1, 2023, CBUS's average daily return is -0.12%, while the average monthly return is -0.50%.

Historically, 47% of months were positive and 53% were negative. The best month was Jul 2023 with a return of +90.5%, while the worst month was Jun 2023 at -59.7%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 4 months.

On a daily basis, CBUS closed higher 46% of trading days. The best single day was Feb 17, 2026 with a return of +41.7%, while the worst single day was Jun 5, 2025 at -34.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202612.07%89.23%-46.34%13.79%
2025-10.43%-17.67%-8.78%14.97%50.23%-57.28%7.25%-9.46%-3.73%24.03%-15.00%27.94%-37.41%
2024-14.71%4.12%28.78%-24.09%-15.19%-31.88%0.41%-31.55%-51.85%22.39%21.80%-42.80%-85.85%
2023-59.69%90.48%-26.65%24.20%-41.00%16.93%56.25%-24.61%

Benchmark Metrics

Cibus Global LLC has an annualized alpha of -47.15%, beta of 2.01, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since June 02, 2023.

  • This stock participated in 254.54% of S&P 500 Index downside but only -108.17% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-47.15%
Beta
2.01
0.07
Upside Capture
-108.17%
Downside Capture
254.54%

Return for Risk

Risk / Return Rank

CBUS ranks 46 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


CBUS Risk / Return Rank: 4646
Overall Rank
CBUS Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
CBUS Sortino Ratio Rank: 5454
Sortino Ratio Rank
CBUS Omega Ratio Rank: 5252
Omega Ratio Rank
CBUS Calmar Ratio Rank: 4040
Calmar Ratio Rank
CBUS Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Cibus Global LLC (CBUS) and compare them to a chosen benchmark (S&P 500 Index).


CBUSBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.05

0.90

-0.85

Sortino ratio

Return per unit of downside risk

0.96

1.39

-0.42

Omega ratio

Gain probability vs. loss probability

1.12

1.21

-0.09

Calmar ratio

Return relative to maximum drawdown

-0.00

1.40

-1.40

Martin ratio

Return relative to average drawdown

-0.00

6.61

-6.61

Explore CBUS risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Cibus Global LLC doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Cibus Global LLC. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cibus Global LLC was 95.55%, occurring on Nov 17, 2025. The portfolio has not yet recovered.

The current Cibus Global LLC drawdown is 92.40%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.55%Jun 2, 2023618Nov 17, 2025

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cibus Global LLC over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Cibus Global LLC is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CBUS relative to other companies in the Biotechnology industry. Currently, CBUS has a P/S ratio of 100.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CBUS in comparison with other companies in the Biotechnology industry. Currently, CBUS has a P/B value of 41.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items